SREBF2 and cancer: Mechanically, DUSP18 increases the activity of the USF1-SREBP2 transcription factor (TF) axis, upregulates the cholesterol biosynthetic pathway and allows for the accumulation of lanosterol, a cholesterol precursor, in cancer cells.